ReviewCancers2026

Integrating Artificial Intelligence, Circulating Tumor DNA, and Real-World Evidence to Optimize Hematologic Clinical Trials: Toward Adaptive and Learning Trial Designs.

Abdurraouf Mokhtar Mahmoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.